|Keio University School of Medicine was founded in 1917, one of the oldest established and leading autoimmune disease care unit and the biggest university hospital in Japan. Currently 29 departments with over 850 physicians and numbers of professors in rheumatology have graduated our center. Both, patients and clinicians largely benefit from the cutting-edge evaluation, treatment and research that is performed in our department. Physician oriented clinical trial that could benefit payers and patients is performed. Off-label use of unapproved drugs for rare disease is also able through the ethics committee that is also a large benefit for patients.
|Division of Allergy, Immunology and Rheumatology of Taichung Veterans General Hospital was founded in July 1982. It is the first division of this specialty in Taiwan. The founder was Dr. Joung-Liang Lan (1982-2002). Second chief was Dr. Der-Yuan Chen (2003-2013). Dr Yi-Hsing Chen is the present (3rd) chief of the Division (2013 till now). Our center is one of the major tertiary referral centers of this field and own the largest patient cohort of rheumatoid arthritis, systemic lupus erythematosus and adult onset Still’s disease in Taiwan. As the first division of this specialty in Taiwan, about one third of the rheumatologists in Taiwan were trained in this Center. Since 2014, we’ve been awarded SNQ of Taiwan by its excellency of clinical care in rheumatic diseases. Our center participates actively in various global clinical trials and work closely with many academic research institutions. We have published more than hundreds of papers in the peer-reviewed medical journals for the past 34 years including Nature Immunology, Annals of Rheumatic Diseases and Arthritis and Rheumatology.
|Rheumatology center in Chang Gung Memorial Hospital provide high-quality, comprehensive and interdisciplinary medical services which can fulfils every need of patients with rheumatic diseases. The seamless teamwork is led by rheumatologists who are responsible for evaluation of patients, identification of patient needs and allocation of optimal resources. Patients are benefited by receiving outstanding medical care and optimal outcomes. The system reduces the cost that may incur due to a lack of efficiency and integration. The generous funding for clinical and translational research support the innovations generated by highly skilled physicians and their team members.
|HUHRD is the first largest hospital for rheumatic diseases in Korea, providing the highest medical services by medical providers with a lot of experiences and know how on various rheumatic diseases. Many domestic and international patients visit us for the differentiated medical services. In addition, the hospital is making efforts to nurture the professional workers in rheumatic treatment and research by providing a systematic education for various kinds of medical workers including private practitioners, researchers and medical providers through various symposiums and educational programs.
|Our vision at the Department of Rheumatology and Immunology, Singapore General Hospital is to be a globally recognised academic department where a passionate team delivers excellent patient-centric healthcare in a vibrant environment for research and education. The a comprehensive range of out-patient services in a one-stop multidisciplinary centre with various sub-specialty clinics. We have a well-recognised programme that delivers rheumatology training to three medical schools and future generations of rheumatologists both locally and regionally. There is a strong research programme helmed by a dedicated team of clinician scientists and clinicians focused on Arthritis (Rheumatoid Arthritis, Spondyloarthritis and Osteoarthritis) and Connective Tissue Diseases (Systemic Lupus Erythematosus and Systemic Sclerosis). The Reverie Rheumatology Research Fund, established in 2014 to raise funds for Rheumatology research, was a ground-up initiative driven by one of our patients. The fund garnered more than 2 million Singapore dollars (SGD) in donationsover 3 years, a testament to the value and impact of our Department’s research. Our clinicians and researchers are thought-leaders in their field, leading in various international (e.g. member of the Outcome Measures in Rheumatology (OMERACT) group), national (e.g. Chair of national biologics registry, the systemic sclerosis research workgroup, residency advisory committee) and hospital-level initiatives (e.g. Chair of the hospital Pharmaceutical and Therapeutics committee, member of the national Pharmaceutical and Therapeutics committee).inaugurated in 2014 provides